HopeStage
Back to all studies
RecruitingNCT07022405

Pramipexole and brain circuit responses in depression

About this titleRead the official source — NCT07022405
Medication studyAges 18–65United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Palo AltoSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 23, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
Stanford University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT07022405
Official title
Show the full official title

Stratified Pharmacological Approaches for Regulating Circuit-Level Effects Study

Recruitment & locations

Currently recruiting

Palo Alto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Stanford University, a university.

Does this study involve medication?

Yes. The study involves medication, including Pramipexole Immediate Release.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies